• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白激酶Cα的激活是佛波酯(TPA)触发的细胞外信号调节激酶(ERK,即丝裂原活化蛋白激酶,MAPK)信号传导及人肝癌细胞HepG2生长抑制所必需的。

Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2.

作者信息

Wen-Sheng Wu, Jun-Ming Huang

机构信息

Department of Medical Technology, TZU CHI University, Taiwan.

出版信息

J Biomed Sci. 2005;12(2):289-96. doi: 10.1007/s11373-005-1210-5.

DOI:10.1007/s11373-005-1210-5
PMID:15917995
Abstract

The signaling mechanisms for most of the antiproliferative processes are not fully understood. We have demonstrated that ERK(MAPK) signaling was involved in the induction of both p15(INK4b)and p16(INK4a) CDK inhibitors and growth inhibition of hepatoma cell HepG2 triggered by the tumor promoter tetradecanoyl phorbol acetate (TPA). In this study, the upstream signal mechanism for TPA-induced ERK(MAPK) activation was investigated. In HepG2 cells only one of the cPKC isozymes, PKCalpha, but not cPKCbetaII, nPKCepsilon or aPKCzeta was activated by TPA as demonstrated by its membrane translocation within 10-30 min and down-regulation at 24 h after TPA treatment. Pretreatment of 0.2-2.0 microM Bisindolylmaleimides, an inhibitor of PKC, attenuated the TPA-induced phosphorylation of ERK, gene expressions of p15(INK4b) and p16(INK4a), and growth inhibition of HepG2 cell in a dose-dependent manner. Consistently, transfection of HepG2 with 1.0-3.0 microM antisense (AS) PKCalpha, but not (AS) PKCbetaII, or nPKCepsilon oligonucleotides (ODN), for 36 h prior to TPA treatment also prevented the TPA-induced molecular and cellular effects described above. Taken together, we concluded that PKCalpha is specifically required for TPA-induced ERK(MAPK) signaling to trigger gene expressions of p15(INK4b) and p16(INK4a) leading to HepG2 growth inhibition.

摘要

大多数抗增殖过程的信号传导机制尚未完全明确。我们已经证明,ERK(丝裂原活化蛋白激酶)信号传导参与了肿瘤启动子十四酰佛波醇乙酸酯(TPA)诱导的p15(INK4b)和p16(INK4a)细胞周期蛋白依赖性激酶抑制剂的产生以及肝癌细胞HepG2的生长抑制。在本研究中,我们对TPA诱导的ERK(MAPK)激活的上游信号机制进行了研究。在HepG2细胞中,只有一种经典蛋白激酶C同工酶PKCalpha可被TPA激活,而不是经典蛋白激酶CbetaII、新型蛋白激酶Cepsilon或非典型蛋白激酶Czeta,这可通过其在TPA处理后10 - 30分钟内的膜转位以及24小时后的下调得以证明。用0.2 - 2.0微摩尔的双吲哚马来酰胺(一种蛋白激酶C抑制剂)预处理,可呈剂量依赖性地减弱TPA诱导的ERK磷酸化、p15(INK4b)和p16(INK4a)的基因表达以及HepG2细胞的生长抑制。同样,在TPA处理前36小时,用1.0 - 3.0微摩尔的反义(AS)PKCalpha而非(AS)PKCbetaII或新型蛋白激酶Cepsilon寡核苷酸(ODN)转染HepG2细胞,也可阻止上述TPA诱导的分子和细胞效应。综上所述,我们得出结论,PKCalpha是TPA诱导的ERK(MAPK)信号传导所特需的,该信号传导可触发p15(INK4b)和p16(INK4a)的基因表达,从而导致HepG2细胞生长抑制。

相似文献

1
Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2.蛋白激酶Cα的激活是佛波酯(TPA)触发的细胞外信号调节激酶(ERK,即丝裂原活化蛋白激酶,MAPK)信号传导及人肝癌细胞HepG2生长抑制所必需的。
J Biomed Sci. 2005;12(2):289-96. doi: 10.1007/s11373-005-1210-5.
2
Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.蛋白激酶Cα触发Ras和Raf非依赖性的MEK/ERK激活,以实现佛波酯诱导的人肝癌细胞HepG2生长抑制。
Cancer Lett. 2006 Jul 28;239(1):27-35. doi: 10.1016/j.canlet.2005.07.034. Epub 2005 Sep 19.
3
ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.ERK信号通路参与了由佛波酯(TPA)和柴胡皂苷a触发的p15INK4b/p16INK4a表达及HepG2细胞生长抑制过程。
Oncogene. 2003 Feb 20;22(7):955-63. doi: 10.1038/sj.onc.1206237.
4
Involvement of p-15(INK4b) and p-16(INK4a) gene expression in saikosaponin a and TPA-induced growth inhibition of HepG2 cells.
Biochem Biophys Res Commun. 2001 Jul 13;285(2):183-7. doi: 10.1006/bbrc.2001.5152.
5
Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2.活性氧介导蛋白激酶Cα和细胞外信号调节激酶的持续激活以促进人肝癌细胞Hepg2迁移。
Mol Cancer Res. 2006 Oct;4(10):747-58. doi: 10.1158/1541-7786.MCR-06-0096.
6
Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation.佛波酯诱导HepG2细胞中低密度脂蛋白受体基因表达涉及蛋白激酶C介导的p42/44丝裂原活化蛋白激酶激活。
J Lipid Res. 1997 Nov;38(11):2240-8.
7
Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cells.
Oncol Rep. 2005 Aug;14(2):489-94.
8
Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate.佛波酯TPA和酪氨酸磷酸酶抑制剂钒酸盐对细胞周期蛋白D1及其信号传导成分的调节作用。
J Cell Physiol. 2001 Mar;186(3):338-49. doi: 10.1002/1097-4652(2000)9999:9999<000::AID-JCP1032>3.0.CO;2-B.
9
Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells.抑制性Smads蛋白Smad6和Smad7的表达在人肺成纤维细胞中受佛波酯(TPA)的差异调节。
Biochem Biophys Res Commun. 2004 Apr 9;316(3):712-9. doi: 10.1016/j.bbrc.2004.02.104.
10
Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.肝细胞生长因子通过ERK依赖和非依赖信号通路下调Id1,导致肝癌细胞中p16INK4a表达增加。
Mol Cancer Res. 2009 Jul;7(7):1179-88. doi: 10.1158/1541-7786.MCR-08-0289. Epub 2009 Jun 30.

引用本文的文献

1
Resveratrol Impairs Insulin Signaling in Hepatic Cells via Activation of PKC and PTP1B Pathways.白藜芦醇通过激活蛋白激酶C和蛋白酪氨酸磷酸酶1B信号通路损害肝细胞中的胰岛素信号。
Int J Mol Sci. 2025 Aug 1;26(15):7434. doi: 10.3390/ijms26157434.
2
Activation of the mitogen-activated protein kinase ERK1/2 signaling pathway suppresses the expression of ChREBPα and β in HepG2 cells.丝裂原活化蛋白激酶 ERK1/2 信号通路的激活抑制 HepG2 细胞中 ChREBPα 和 β 的表达。
FEBS Open Bio. 2021 Jul;11(7):2008-2018. doi: 10.1002/2211-5463.13208. Epub 2021 Jun 17.
3
The complexities of PKCα signaling in cancer.
PKCα 信号在癌症中的复杂性。
Adv Biol Regul. 2021 May;80:100769. doi: 10.1016/j.jbior.2020.100769. Epub 2020 Nov 23.
4
Protein kinase C-α is upregulated by IMP1 in melanoma and is linked to poor survival.IMP1 上调黑色素瘤中的蛋白激酶 C-α,与不良预后相关。
Melanoma Res. 2019 Oct;29(5):539-543. doi: 10.1097/CMR.0000000000000558.
5
Regulations of Reversal of Senescence by PKC Isozymes in Response to 12-O-Tetradecanoylphorbol-13-Acetate via Nuclear Translocation of pErk1/2.蛋白激酶C同工酶通过pErk1/2核转位响应12-O-十四烷酰佛波醇-13-乙酸酯逆转衰老的调控
Mol Cells. 2016 Mar;39(3):266-79. doi: 10.14348/molcells.2016.2362. Epub 2016 Feb 24.
6
DcR3 suppresses influenza virus-induced macrophage activation and attenuates pulmonary inflammation and lethality.DcR3抑制流感病毒诱导的巨噬细胞活化,并减轻肺部炎症和致死率。
J Mol Med (Berl). 2015 Oct;93(10):1131-43. doi: 10.1007/s00109-015-1291-1. Epub 2015 May 5.
7
PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.PKCalpha 介导的人肝癌 HepG2 细胞中 miR-101 的诱导。
J Biomed Sci. 2010 May 6;17(1):35. doi: 10.1186/1423-0127-17-35.
8
H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.H3 组氨酸受体介导致蛋白激酶 Calpha 的激活抑制胆管癌细胞在体外和体内的生长。
Mol Cancer Res. 2009 Oct;7(10):1704-13. doi: 10.1158/1541-7786.MCR-09-0261. Epub 2009 Oct 13.
9
Protein kinase Calpha-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites.蛋白激酶Cα通过ERK介导的HDAC1/Sin3A阻遏复合物从Sp1位点的释放,诱导人促黄体生成素受体基因转录去抑制。
Mol Endocrinol. 2008 Jun;22(6):1449-63. doi: 10.1210/me.2008-0035. Epub 2008 Mar 27.
10
Chronic hepatitis B in hepatocarcinogenesis.慢性乙型肝炎与肝癌发生
Postgrad Med J. 2006 Aug;82(970):507-15. doi: 10.1136/pgmj.2006.047431.